Gilching (pta/12.12.2022/15:10) -
As already announced on November 2, 2022, the Executive Board of Dr. Hönle AG decided to close the subsidiary Raesch Quarz (Germany) GmbH, Ilmenau, and to sell all the assets. Fortunately, an agreement has now been reached on the sale of the entire company to a new owner. Business operations therefore can be continued with the existing employees. The sale will take place retrospectively as of December 1, 2022. The purchase price is in the mid-single-digit million range.
By selling the company all financial and legal risks from the redundancy package regulations as well as claims from customers and suppliers from the originally planned closure of the company are eliminated. The cashflow from the purchase price payment will take place in full till December 31, 2022. The sales and earnings targets communicated for the Hönle Group remain unchanged despite the sale of Raesch Quarz (Germany) GmbH.
Dr. Hönle AG is a leading provider of industrial UV technology based in Gilching. With more than 600 employees, the Hönle Group develops innovative solutions for different areas of application. A focus of its business activities is the development and sale of industrial adhesives and casting compounds. Equipment for drying ink and coatings, curing adhesives and plastics, as well as for disinfecting air, water and surfaces and sunlight simulation are also manufactured. In addition, the group of companies produces UV lamps and products made of quartz glass, among other things for disinfection and drying processes. The Hönle Group supplies technology and global market leaders and is represented by its own companies and partner companies in more than 20 countries.
Dr. Hönle AG
|Contact Person:||Peter Weinert|
|Phone:||+49 8105 2083 173|
|Stock Exchange(s):||Regulated Market in Frankfurt, Free Market in Berlin, Free Market in Dusseldorf, Free Market in Hamburg, Free Market in Hannover, Free Market in Munich, Free Market in Stuttgart, Open Market in Tradegate|